« Previous
Next »
Leukemia Research
Volume 28, Issue 3
, Pages 219-220
, March 2004
Comparative gene expression profile of p185Bcr-Abl versus p210Bcr-Abl expressing cells
References
- . Cytogenetic and molecular genetic aspects of chronic myeloid leukaemia. Acta Haematol. 2002;108:180–202
- . Imatinib: the first 3 years. Eur. J. Cancer. 2002;38(Suppl 5):S77–S82
- Mutator phenotype of BCR-ABL transfected Ba/F3 cell lines and its association with enhanced expression of DNA polymerase beta. Oncogene. 1999;18:2676–2680
-
.
p53 mutations, methylation and genomic instability in the progression of chronic myeloid leukaemia.
Leuk. Lymph. 1997;26:211–226
- . Secondary mutation maintains the transformed state in BaF3 cells with inducible BCR/ABL expression. Blood. 1998;91:3927–3934
- . The diversity of BCR-ABL fusion proteins and their relationship to leukemia phenotype. Blood. 1996;88:2375–2384 [editorial]
- . P190BCR-ABL chronic myeloid leukaemia: the missing link with chronic myelomonocytic leukaemia?. Leukemia. 1994;8:208–211
- Chronic myelogenous leukaemia with p185 (BCR/ABL) expression: characteristics and clinical significance. Br. J. Haematol. 1999;107:581–586
-
Advani AS, et al. Data on gene expression profiling of cells with p210 and p185 BCR-ABL fusion genes. Leuk Res, in press [report].
- . Isolation of a gene encoding a developmentally regulated T cell-specific protein with a guanine nucleotide triphosphate-binding motif. J. Immunol. 1995;154:1724–1734
- Primitive interleukin 3 null hematopoietic cells transduced with BCR-ABL show accelerated loss after culture of factor-independence in vitro and leukemogenic activity in vivo. Blood. 2002;100:3731–3740
PII: S0145-2126(03)00269-8
doi: 10.1016/j.leukres.2003.07.004
© 2003 Elsevier Ltd. All rights reserved.
« Previous
Next »
Leukemia Research
Volume 28, Issue 3
, Pages 219-220
, March 2004
